Showing results (591-600 of 669) with videos related to
Sort By:
Pageof 67
Infection and Immunity|January 27, 2004
Two studies evaluating the safety and immunogenicity of a live, attenuated Shigella flexneri 2a vaccine (SC602) and excretion of vaccine organisms in North American volunteersDavid E Katz, Trinka S Coster, Marcia K Wolf, et al.The American Journal of Pathology|August 31, 2010
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomasKwong-Kwok Wong, Yvonne T M Tsang, Michael T Deavers, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2008
Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitorsF Moreau, N Desroy, J M Genevard, et al.Cancer|July 29, 2010
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trialJubilee Brown, Judith A Smith, Lois M Ramondetta, et al.Mededportal : the Journal of Teaching and Learning Resources|April 16, 2019
A Structured, Debate-Style Cardiothoracic Surgery Journal Club for Trainee Acquisition and Application of Seminal LiteratureMara B Antonoff, Tom C Nguyen, Jessica G Y Luc, et al.Biomaterials Advances|August 22, 2022
Mechanical stimulation of a bioactive, functionalized PVDF-TrFE scaffold provides electrical signaling for nerve repair applicationsJacob A Orkwis, Ann K Wolf, Zachary J Mularczyk, et al.Gynecologic Oncology|June 25, 2003
Overexpression of kallikrein 10 in epithelial ovarian carcinomasHyun S Shvartsman, Karen H Lu, John Lee, et al.Investigative Ophthalmology & Visual Science|October 25, 2012
The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.Investigative Ophthalmology & Visual Science|August 18, 2012
"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasiaFerenc B Sallo, Tunde Peto, Catherine Egan, et al.Infection and Immunity|November 1, 2006
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coliT S Coster, M K Wolf, E R Hall, et al.Pageof 67